Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to 0.23.

  • Assembly Biosciences' Asset Utilization Ratio fell 1175.95% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year decrease of 1175.95%. This contributed to the annual value of 0.22 for FY2024, which is 27113.44% up from last year.
  • As of Q3 2025, Assembly Biosciences' Asset Utilization Ratio stood at 0.23, which was down 1175.95% from 0.37 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Asset Utilization Ratio registered a high of 0.37 during Q2 2025, and its lowest value of 0.03 during Q4 2021.
  • In the last 5 years, Assembly Biosciences' Asset Utilization Ratio had a median value of 0.16 in 2021 and averaged 0.17.
  • Over the last 5 years, Assembly Biosciences' Asset Utilization Ratio had its largest YoY gain of 43949.27% in 2021, and its largest YoY loss of 8964.83% in 2021.
  • Over the past 5 years, Assembly Biosciences' Asset Utilization Ratio (Quarter) stood at 0.03 in 2021, then skyrocketed by 43.72% to 0.04 in 2022, then skyrocketed by 86.08% to 0.08 in 2023, then skyrocketed by 241.95% to 0.26 in 2024, then dropped by 10.8% to 0.23 in 2025.
  • Its last three reported values are 0.23 in Q3 2025, 0.37 for Q2 2025, and 0.29 during Q1 2025.